latest update:
[TrialBase DB]

trial summary · NCT07853781

First-in-Human Evaluation of [11C]JMJ-129-d2 for PDE4D Imaging in Healthy Volunteers

Trial record from the TrialBase DB dataset, status RECRUITING, condition Healthy, sponsored by National Institute of Mental Health (NIMH). Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07853781phase PHASE1enrollment 40start 2026-11-04

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

Background: PDE4D is a protein found in the brain. It helps control chemical signals that affect mood, memory, and thinking. Problems with PDE4D may play a role in depression and Alzheimer's disease. Being able to measure PDE4D levels in the body would help doctors identify and manage these diseases. Researchers want to find out if a new tracer (a radioactive substance injected during imaging scans) can help them see PDE4D in people more effectively. Objective: To test a new tracer (\[11C\]JMJ-129-d2) during imaging scans of the brain and body in healthy people. Eligibility: Healthy people aged 18 years and older. They must have been screened under protocols 01M0254 or 17M0181. Design: All participants will give samples of blood and urine. They will have a test of their heart function. A plastic tube will be inserted into a vein in their arm; the new tracer will be given through this tube. Some participants will have 1 positron emission tomography (PET)/computed tomography (CT) scan of their whole body. They will lie on a padded bed that slides into a doughnut-shaped machine; the machine uses x-rays to create images of the inside of the body. Some participants will have 1 or 2 PET/CT scans of their brain only. Their head will be supported to keep it still during the scan. They will also have a magnetic resonance imaging (MRI) scan of the brain. MRI uses magnetic fields to capture images of the inside of the body. The MRI scan may require a second visit. All participants will receive a follow-up call to check on their well-being 1 to 3 business days after their scans.

Source record: https://clinicaltrials.gov/study/NCT07853781

Facts

registry idNCT07853781
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasePHASE1
study typeINTERVENTIONAL
lead conditionHealthy
sponsorNational Institute of Mental Health (NIMH)
sponsor classNIH
enrollment40
start date2026-11-04
primary completion2030-02-22
completion2031-02-05
results postednot reported

Conditions

  • Healthy

Interventions

  • [11C]JMJ-129-d2

Countries

  • United States

Intervention types: DRUG

Work with this record